Next Generation DNA Sequencing (NGS) Market research report displays key data and information about several factors which helps achieve success in the competitive marketplace. Summary of the market is analysed with respect to market players who are mainly customers, businesses or clients. SWOT analysis is the standard, prominent and full-proof method to perform the market research study which is used to formulate this particular Global Next Generation DNA Sequencing (NGS) Market report. To be ahead of the competition, a systematic idea about the competitive landscape, their product range, their strategies, and future prospects are very important. Market risks and entry barriers makes Healthcare industry aware and help deciding further moves.

In recent years, the next generation DNA sequencing (NGS) market is anticipated to grow rapidly during the forecast period owing to the high prevalence rate of cancer. Next-generation sequencing is a DNA sequencing method that determines the exact arrangement of nucleotides within a DNA molecule. A million DNA molecules and RNA sequences are generated every second by the next-generation sequencer, enabling for rapid sequencing. Next-generation sequencing refers to high-throughput sequencing (NSG).

Data Bridge Market Research analyses that the next generation DNA sequencing (NGS) market was valued at USD 9.4 billion in 2021 and is expected to reach USD 40.42 billion by 2029, registering a CAGR of 20% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Download Sample PDF of Global Next Generation DNA Sequencing (NGS) Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-next-generation-dna-sequencing-ngs-market

The method of determining the sequence of nucleotides in a piece of DNA is known as next-generation sequencing, or high-throughput sequencing. Sequencing by synthesis (SBS), ion semiconductor sequencing, nanopore sequencing, and single-molecule real-time (SMRT) sequencing are some of the techniques used. It is a cost-effective solution that provides precise, high-accuracy, and fast outcomes.

Some of the major players operating in the next generation DNA sequencing (NGS) market are:

·         Illumina, Inc. (US)

·         Thermo Fisher Scientific Inc. (US)

·         PerkinElmer, Inc. (US)

·         BGI Group (China)

·         Agilent Technologies, Inc. (US)

·         Eurofins Scientific (Luxembourg)

·         PacBio (US)

·         Oxford Nanopore Technologies plc (UK)

·         QIAGEN (Netherlands)

·         F. Hoffmann-La Roche Ltd. (Switzerland)

·         GENEWIZ Inc. (US)

·         Psomagen (South Korea)

·         10x Genomics (US)

·         Takara Bio Inc (Japan)

·         Bio-Rad Laboratories, Inc. (US)

·         Zymo Research Corporation (US)

·         Tecan Trading AG (Switzerland)

·         Hamilton Company (US)

·         Beckman Coulter, Inc. (US)

·         BD (US)

·         Lucigen Corporation (US)

·         Novogene Co., Ltd. (China)

Next Generation DNA Sequencing (NGS) Market Dynamics

Drivers

·         Increasing Prevalence of Chronic Diseases

The rising prevalence of chronic diseases such as cancer will propel the market’s growth rate during the forecast period of 2022-2029. There has been a tremendous growth in the use of NGS technology as a result of the widespread acceptance of liquid biopsies in cancer diagnoses. Cell-free circulating tumor DNA (ctDNA) is used as a non-invasive cancer biomarker for real-time cancer monitoring and detection in these technologies.

·         Rise in the Adoption of Genome Mapping Programs

The market is also benefiting from the growing use of genomic mapping programmes to anticipate the development of various diseases. Scientists utilize genetic maps to help them figure out which genes are linked to rising rates of diabetes, heart disease, asthma, cancer, and psychiatric disorders.

 

Furthermore, the growing geriatric population will act as major factor influencing the growth of next generation DNA sequencing (NGS) market. Along with this, increasing urbanization and rising level of disposable income are the driving factors accelerating the growth of the next generation DNA sequencing (NGS) market. Also, increasing expenditure on healthcare infrastructure and rising use of NGS technology by pharmaceutical and biopharmaceutical companies are the major market drivers that will further escalate the growth of next generation DNA sequencing (NGS) market.

Browse a Detailed Summary of the Global Next Generation DNA Sequencing (NGS) Market Research Report @ https://www.databridgemarketresearch.com/reports/global-next-generation-dna-sequencing-ngs-market

Recent Development

·         In January 2021, The Thalassemia Gene Detection Kit (Combinatorial Probe-Anchor Synthesis Sequencing Method) from BGI Group had acquired CE mark approval for genetic diagnosis of á, â thalassemia and other hemoglobinopathies, as well as general population carrier screening.

Global Next Generation DNA Sequencing (NGS) Market Scope

The next generation DNA sequencing (NGS) market is segmented on the basis of product, applications and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

·         Instruments

·         Consumables

·         Services

Based on product, next generation DNA sequencing (NGS) market is segmented into instruments, consumables, and services.

Applications

·         Diagnostics

·         Biomarker Discovery

·         Precision Medicine

·         Drug Discovery

·         Agriculture and Animal Research

·         Others

On the basis of application, next generation DNA sequencing (NGS) market is segmented into diagnostics, biomarker discovery, precision medicine, drug discovery, agriculture and animal research and others.

End User

·         Pharmaceutical and Biotechnology Companies

·         Research Centers and Academic

·         Government Institutes

·         Hospital and Clinics

Next generation DNA sequencing (NGS) market has also been segmented based on the end user into pharmaceutical and biotechnology companies, research centers and academic and government institutes, hospital and clinics.

To Check the Complete Table Of contents, click here @ https://www.databridgemarketresearch.com/toc/?dbmr=global-next-generation-dna-sequencing-ngs-market

This Market Intelligence Report Analyses Some of the Most Crucial Concerns:

                     How will the major segments of this international market develop over the next few years?

                     Who are the major players that will dominate the market in the future?

                     When it comes to this industry, who are the top suppliers and producers?

                     How have the most successful companies in the industry planned for future growth and expansion?

                     In what sectors might we expect to see the greatest increase in demand over the coming years?

                     How many distinct subsets of buyers make up this market?

                     Which regional powerhouse do you foresee as becoming the largest player in the international market?

                     Does a new coronavirus pandemic have any consequences?

                     In what ways are established actors stymied by the entry of newcomers, and how may they be overcome?

Browse More Reports

https://www.databridgemarketresearch.com/reports/global-sequencing-kits-market

https://www.databridgemarketresearch.com/reports/global-next-generation-sequencing-data-analysis-market

https://www.databridgemarketresearch.com/reports/global-clinical-oncology-next-generation-sequencing-market

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Corporatesales@databridgemarketresearch.com